Expression of the pro-angiogenic factors vascular endothelial growth factor and interleukin-8/CXCL8 by human breast carcinomas is responsive to nutrient deprivation and endoplasmic reticulum stress

被引:67
|
作者
Marjon, Philip L. [1 ]
Bobrovnikova-Marjon, Ekaterina V. [1 ]
Abcouwer, Steve F. [1 ]
机构
[1] Univ New Mexico, Sch Med, Dept Biochem & Mol Biol, Albuquerque, NM 87131 USA
关键词
Angiogenesis; Breast cancer; Brefeldin A; Glucose; Glucose-regulated protein 78 (GRP78); Glutamine; Growth arrest and DNA damage inducible gene 153 (GADD153); Hypoxia; Ionomycin; Thapsigargin; Tunicamycin;
D O I
10.1186/1476-4598-3-4
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Background: The expression of pro-angiogenic cytokines, such as vascular endothelial growth factor (VEGF) and interleukin-8/CXCL8 (IL-8), plays an important role in tumor growth and metastasis. Low oxygen tension within poorly-vascularized tumors is thought to be the prime stimulus causing the secretion of VEGF. The expression of IL-8 by solid tumors is thought to be primarily due to intrinsic influences, such as constitutive activation of nuclear factor kappa B (NF-kappa B). However, VEGF expression is responsive to glucose deprivation, suggesting that low concentrations of nutrients other than oxygen may play a role in triggering the pro-angiogenic phenotype. Glucose deprivation causes endoplasmic reticulum (ER) stress and alters gene expression through the unfolded protein response (UPR) signaling pathway. A branch of the UPR, known as the ER overload response (EOR), can cause NF-kappa B activation. Thus, we hypothesized that treatments that cause ER stress and deprivation of other nutrients, such as amino acids, would trigger the expression of angiogenic cytokines by breast cancer cell lines. Results: We found that glutamine deprivation and treatment with a chemical inducer of ER stress (tunicamycin) caused a marked induction of the secretion of both VEGF and IL-8 protein by a human breast adenocarcinoma cell line (TSE cells). Glutamine deprivation, glucose deprivation and several chemical inducers of ER stress increased VEGF and IL-8 mRNA expression in TSE and other breast cancer cell lines cultured under both normoxic and hypoxic conditions, though hypoxia generally diminished the effects of glucose deprivation. Of all amino acids tested, ambient glutamine availability had the largest effect on VEGF and IL-8 mRNA expression. The induction of VEGF mRNA expression, but not IL-8, was sustained and closely corresponded with the upregulated expression of the ER stress-responsive genes glucose-regulated protein 78 (GRP78) and growth arrest and DNA damage inducible gene 153 (GADD153). Conclusion: These results suggest that nutrient deprivation within the solid tumor microenvironment might contribute to the activation of a pro-angiogenic phenotype. The angiogenic switch may act to increase blood supply in response to nutrient deprivation as well as hypoxia.
引用
收藏
页数:12
相关论文
共 50 条
  • [1] Expression of the pro-angiogenic factors vascular endothelial growth factor and interleukin-8/CXCL8 by human breast carcinomas is responsive to nutrient deprivation and endoplasmic reticulum stress
    Philip L Marjon
    Ekaterina V Bobrovnikova-Marjon
    Steve F Abcouwer
    [J]. Molecular Cancer, 3
  • [2] Nutrient deprivation and chemical inducers of endoplasmic reticulum stress upregulate the expression of proangiogenic factors vascular endothelial growth factor (VEGF) and interleukin-8 (IL-8)
    Marjon, PL
    Bobrovnikova, YV
    Abcouwer, SF
    [J]. FASEB JOURNAL, 2003, 17 (05): : A1369 - A1369
  • [3] Expression of angiogenic factors vascular endothelial growth factor and interleukin-8/CXCL8 is highly responsive to ambient glutamine availability:: Role of nuclear Factor-κB and activating protein-1
    Bobrovnikova-Marjon, EV
    Marjon, PL
    Barbash, O
    Jagt, DLV
    Abcouwer, SF
    [J]. CANCER RESEARCH, 2004, 64 (14) : 4858 - 4869
  • [4] Interleukin-8/CXCL8 is a growth factor for human lung cancer cells
    Zhu, YM
    Webster, SJ
    Flower, D
    Woll, PJ
    [J]. BRITISH JOURNAL OF CANCER, 2004, 91 (11) : 1970 - 1976
  • [5] Interleukin-8/CXCL8 is a growth factor for human lung cancer cells
    Y M Zhu
    S J Webster
    D Flower
    P J Woll
    [J]. British Journal of Cancer, 2004, 91 : 1970 - 1976
  • [6] Toll-like receptor 2 ligand mediates the upregulation of angiogenic factor, vascular endothelial growth factor and interleukin-8 CXCL8 in human rheumatoid synovial fibroblasts
    Cho, Mi-La
    Ju, Ji-Hyeon
    Kim, Hae-Rim
    Oh, Hye-Joa
    Kang, Chang-Min
    Jhun, Joo-Yeon
    Lee, Seon-Yeong
    Park, Mi-Kyung
    Min, Jun-Ki
    Park, Sung-Hwan
    Lee, Sang-Heon
    Kim, Ho-Youn
    [J]. IMMUNOLOGY LETTERS, 2007, 108 (02) : 121 - 128
  • [7] Transactivation of vascular endothelial growth factor receptor-2 by interleukin-8 (IL-8/CXCL8) is required for IL-8/CXCL8-induced endothelial permeability
    Petreaca, Melissa L.
    Yao, Min
    Liu, Yan
    DeFea, Kathryn
    Martins-Green, Manuela
    [J]. MOLECULAR BIOLOGY OF THE CELL, 2007, 18 (12) : 5014 - 5023
  • [8] Interleukin 8 and vascular endothelial growth factor - prognostic factors in human gastric carcinomas?
    Kido, S
    Kitadai, Y
    Hattori, N
    Haruma, K
    Kido, T
    Ohta, M
    Tanaka, S
    Yoshihara, M
    Sumii, K
    Ohmoto, Y
    Chayama, K
    [J]. EUROPEAN JOURNAL OF CANCER, 2001, 37 (12) : 1482 - 1487
  • [9] Expression of angiostatic platelet factor-4var/CXCL4L1 counterbalances angiogenic impulses of vascular endothelial growth factor, interleukin-8/CXCL8, and stromal cell-derived factor 1/CXCL12 in esophageal and colorectal cancer
    Verbeke, Hannelien
    De Hertogh, Gert
    Li, Sandra
    Vandercappellen, Jo
    Noppen, Samuel
    Schutyser, Evemie
    Abu El-Asrar, Ahmed
    Opdenakker, Ghislain
    Van Damme, Jo
    Geboes, Karel
    Struyf, Sofie
    [J]. HUMAN PATHOLOGY, 2010, 41 (07) : 990 - 1001
  • [10] Role of angiogenic factors: Coexpression of interleukin-8 and vascular endothelial growth factor in patients with head and neck squamous carcinoma
    Eisma, RJ
    Spiro, JD
    Kreutzer, DL
    [J]. LARYNGOSCOPE, 1999, 109 (05): : 687 - 693